FI893681A0 - N-2,3-butadienyltri- och tetra-aminoalkanderivat. - Google Patents

N-2,3-butadienyltri- och tetra-aminoalkanderivat.

Info

Publication number
FI893681A0
FI893681A0 FI893681A FI893681A FI893681A0 FI 893681 A0 FI893681 A0 FI 893681A0 FI 893681 A FI893681 A FI 893681A FI 893681 A FI893681 A FI 893681A FI 893681 A0 FI893681 A0 FI 893681A0
Authority
FI
Finland
Prior art keywords
butadienyltry
alkandanders
tetra
tetra amino
polyamines
Prior art date
Application number
FI893681A
Other languages
English (en)
Other versions
FI893681A (fi
Inventor
Philippe Bey
David Martin Stemerick
Michael Louis Edwards
Alan Joseph Bitonti
Original Assignee
Merrell Dow Pharma
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Merrell Dow Pharma filed Critical Merrell Dow Pharma
Publication of FI893681A0 publication Critical patent/FI893681A0/fi
Publication of FI893681A publication Critical patent/FI893681A/fi

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
    • C07C211/00—Compounds containing amino groups bound to a carbon skeleton
    • C07C211/01—Compounds containing amino groups bound to a carbon skeleton having amino groups bound to acyclic carbon atoms
    • C07C211/20—Compounds containing amino groups bound to a carbon skeleton having amino groups bound to acyclic carbon atoms of an acyclic unsaturated carbon skeleton
    • C07C211/21—Monoamines
    • A—HUMAN NECESSITIES
    • A01—AGRICULTURE; FORESTRY; ANIMAL HUSBANDRY; HUNTING; TRAPPING; FISHING
    • A01N—PRESERVATION OF BODIES OF HUMANS OR ANIMALS OR PLANTS OR PARTS THEREOF; BIOCIDES, e.g. AS DISINFECTANTS, AS PESTICIDES OR AS HERBICIDES; PEST REPELLANTS OR ATTRACTANTS; PLANT GROWTH REGULATORS
    • A01N33/00—Biocides, pest repellants or attractants, or plant growth regulators containing organic nitrogen compounds
    • A01N33/02—Amines; Quaternary ammonium compounds
    • A01N33/04—Nitrogen directly attached to aliphatic or cycloaliphatic carbon atoms
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/13—Amines
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P33/00—Antiparasitic agents
    • A61P33/02—Antiprotozoals, e.g. for leishmaniasis, trichomoniasis, toxoplasmosis
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
    • Y—GENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y02—TECHNOLOGIES OR APPLICATIONS FOR MITIGATION OR ADAPTATION AGAINST CLIMATE CHANGE
    • Y02A—TECHNOLOGIES FOR ADAPTATION TO CLIMATE CHANGE
    • Y02A50/00—TECHNOLOGIES FOR ADAPTATION TO CLIMATE CHANGE in human health protection, e.g. against extreme weather
    • Y02A50/30—Against vector-borne diseases, e.g. mosquito-borne, fly-borne, tick-borne or waterborne diseases whose impact is exacerbated by climate change

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Animal Behavior & Ethology (AREA)
  • Epidemiology (AREA)
  • Engineering & Computer Science (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Zoology (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Environmental Sciences (AREA)
  • General Chemical & Material Sciences (AREA)
  • Agronomy & Crop Science (AREA)
  • Pest Control & Pesticides (AREA)
  • Plant Pathology (AREA)
  • Dentistry (AREA)
  • Wood Science & Technology (AREA)
  • Tropical Medicine & Parasitology (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Non-Silver Salt Photosensitive Materials And Non-Silver Salt Photography (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
FI893681A 1988-08-04 1989-08-03 N-2,3-butadienyltri- och tetra-aminoalkanderivat. FI893681A (fi)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
US07/228,620 US4935449A (en) 1988-08-04 1988-08-04 N-2,3-butadienyl tri- and tetraaminoalkane derivatives

Publications (2)

Publication Number Publication Date
FI893681A0 true FI893681A0 (fi) 1989-08-03
FI893681A FI893681A (fi) 1990-02-05

Family

ID=22857945

Family Applications (1)

Application Number Title Priority Date Filing Date
FI893681A FI893681A (fi) 1988-08-04 1989-08-03 N-2,3-butadienyltri- och tetra-aminoalkanderivat.

Country Status (19)

Country Link
US (1) US4935449A (fi)
EP (1) EP0353752B1 (fi)
JP (1) JP2722255B2 (fi)
KR (1) KR0144155B1 (fi)
CN (1) CN1039800A (fi)
AT (1) ATE99669T1 (fi)
AU (1) AU617502B2 (fi)
CA (1) CA1321603C (fi)
DE (1) DE68912020T2 (fi)
DK (1) DK381189A (fi)
ES (1) ES2061826T3 (fi)
FI (1) FI893681A (fi)
HU (1) HU207833B (fi)
IL (1) IL91184A0 (fi)
NO (1) NO172043C (fi)
NZ (1) NZ230155A (fi)
PH (1) PH27214A (fi)
PT (1) PT91365A (fi)
ZA (1) ZA895840B (fi)

Families Citing this family (14)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
GB9111794D0 (en) * 1991-05-31 1991-07-24 Robins David J Antifungal compounds
DE69412467T2 (de) * 1993-12-27 1999-01-28 Novartis Ag, Basel Ungesättigte aminoverbindungen zur verwendung als antikrebsmittel und als mittelgegen protozoen
US5677350A (en) * 1995-06-07 1997-10-14 Wisconsin Alumni Research Foundation Inhibition of cancer cell growth, proliferation, and metastasis using N,N'-dα,ω-diaminoalkanes
US6482943B1 (en) 1999-04-30 2002-11-19 Slil Biomedical Corporation Quinones as disease therapies
US6794545B1 (en) * 1999-04-30 2004-09-21 Slil Biomedical Corporation Conformationally restricted polyamine analogs as disease therapies
US6649587B1 (en) 1999-04-30 2003-11-18 Slil Biomedical Corporation Polyamine analog conjugates and quinone conjugates as therapies for cancers and prostate diseases
JP2002543163A (ja) * 1999-04-30 2002-12-17 スリル バイオメディカル コーポレイション 癌および前立腺疾患のための治療としての結合体
AU2002235126A1 (en) * 2000-11-08 2002-05-21 Slil Biomedical Corporation Novel polyamine analog-amino acid conjugates useful as anticancer agents
WO2003013245A1 (en) * 2001-08-07 2003-02-20 Wisconsin Alumni Research Foundation Polyamines and analogs for protecting cells during cancer chemotherapy and radiotherapy
AU2002343609B2 (en) * 2001-11-16 2008-12-11 Als Therapy Development Foundation, Inc. Treatment of neurodegenerative disorders through the modulation of the polyamine pathway
WO2003050072A1 (en) 2001-12-07 2003-06-19 Slil Biomedical Corporation Cycloalkyl substituted polyamines for cancer therapy and methods of synthesis therefor
MXPA04007584A (es) * 2002-02-07 2004-12-06 Wisconsin Alumni Res Found Compuestos de poliamina y composiciones para su uso en conjunto con una terapia contra el cancer.
IN2012DE00661A (fi) 2012-03-07 2015-08-21 Univ Delhi
CN102924390B (zh) * 2012-09-07 2014-12-31 苏州康润医药有限公司 1,5-二氮杂环辛烷-1-甲酸叔丁酯的合成方法

Family Cites Families (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
ATE25965T1 (de) * 1983-12-06 1987-04-15 Merrell Dow Pharma N-2,3-butadienyl-1,4-butadiamin-derivate.
US4551550A (en) * 1983-12-06 1985-11-05 Merrell Dow Pharmaceuticals Inc. N-2,3-Butadienyl-1,4-butanediamine derivatives
AU602186B2 (en) * 1987-02-03 1990-10-04 Merrell Dow Pharmaceuticals Inc. Novel polyamine derivatives
US5120764A (en) * 1988-11-01 1992-06-09 Merrell Dow Pharmaceuticals Inc. Inhibitors of lysyl oxidase

Also Published As

Publication number Publication date
NO172043B (no) 1993-02-22
EP0353752B1 (en) 1994-01-05
IL91184A0 (en) 1990-03-19
ES2061826T3 (es) 1994-12-16
DK381189A (da) 1990-02-05
ZA895840B (en) 1990-04-25
PT91365A (pt) 1990-03-08
KR900003105A (ko) 1990-03-23
ATE99669T1 (de) 1994-01-15
HUT58037A (en) 1992-01-28
AU3927189A (en) 1990-02-08
CN1039800A (zh) 1990-02-21
AU617502B2 (en) 1991-11-28
JPH0283357A (ja) 1990-03-23
US4935449A (en) 1990-06-19
NO893135L (no) 1990-02-05
NO172043C (no) 1993-06-02
CA1321603C (en) 1993-08-24
DE68912020T2 (de) 1994-04-28
KR0144155B1 (ko) 1998-07-15
FI893681A (fi) 1990-02-05
DK381189D0 (da) 1989-08-03
HU207833B (en) 1993-06-28
JP2722255B2 (ja) 1998-03-04
EP0353752A1 (en) 1990-02-07
DE68912020D1 (de) 1994-02-17
NO893135D0 (no) 1989-08-03
NZ230155A (en) 1991-08-27
PH27214A (en) 1993-05-04

Similar Documents

Publication Publication Date Title
AU586860B2 (en) Therapeutical application of phosphonylmethoxyalkyl adenines
FI893681A (fi) N-2,3-butadienyltri- och tetra-aminoalkanderivat.
IT8847884A0 (it) Elettrodo enzimatico e modulo di elettrodo nonche' relativo metodo di impiego
DE3785684D1 (de) Pyrrolidinamid-derivate von acylaminosaeure, pharmazeutische zusammensetzung und verwendung.
IT1232827B (it) Proteine biologicamente attive, formulazioni che le contengono e metodo per prepararle ed applicarle
ES2151607T3 (es) Factor 12 de crecimiento y de diferenciacion.
DE59407457D1 (de) Blockierung der anlagerung von keimen an menschliche zellen
FI940375A (fi) Peptidit, joilla on elimiä suojaavaa vaikutusta, menetelmä niiden valmistamiseksi ja niiden käyttö terapiassa
FI102293B1 (fi) Ihmisen interleukiini-3:n molekulaarinen kloonaus ja ilmentäminen
ES2177625T3 (es) Citoquina cc-1 humana circulante.
GR880100775A (el) Παράγοντας ενεργοποιήσεως ουδετεροφίλων.
ES2057004T3 (es) N-alcoxialquilamidas de hidroxiacidos y composiciones a base de las mismas para el tratamiento de la piel.
BG50159A3 (en) Method for preparing derivatives of piranobenzadiasole
FI922428A0 (fi) Nya 2-amino-5-cyan-1,4- dihydropyridiner, foerfarande foer deras framstaellning och deras anvaendning i laekemedel.
ATE45675T1 (de) Verwendung von interferon gamma (ifn-gamma) zur herstellung von praeparationen zur behandlung rheumatischer erkrankungen.
DK89489A (da) Anvendelse af halogenerede allylaminer til fremstilling af et farmaceutisk praeparat
IT1283899B1 (it) Peptidi e loro usi nella terapia della malattia celiaca
TR199700842T1 (xx) �nsan DNase I Varyantlar�.
ATE62789T1 (de) Mittel zur bekaempfung von phytopathogenen mikroben.
DE3777359D1 (de) Aminosaeuresequenz des menschlichen alpha 2-plasmininhibitors und cdns sowie diese aminosaeuresequenz codierende genomische dns.
DE59611330D1 (de) Arzneimittel enthaltend wenigstens einen teil des ul84-proteins des cytomegalovirus, verwendung von polypeptiden entsprechend der aminosäuresequenz des ul84-proteins und verfahren zur einführung von ul84 in zielzellen
SE8802323D0 (sv) 8alfa-acylaminoergoline, its preparation and pharmaceutical compositions containing it
IT8622051A0 (it) Composizioni farmaceutiche adattivita' cicatrizzante.
IT1216188B (it) Strumento indicatore del grado di abbronzatura dell'epidermide.
ATE88090T1 (de) Verwendung von acetyl-d-carnitin zur therapeutischen behandlung von glaukom.

Legal Events

Date Code Title Description
FA Application withdrawn

Owner name: MERRELL DOW PHARMACEUTICALS INC.